Detalhe da pesquisa
1.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589856
2.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Br J Cancer
; 128(5): 877-885, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482190
3.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.
Liver Int
; 43(8): 1803-1812, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452505
4.
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study.
Int J Cancer
; 151(8): 1310-1320, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723131
5.
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience.
Future Oncol
; 18(24): 2651-2659, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791815
6.
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.
Oncology
; 99(5): 292-299, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626532
7.
Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer.
BMC Cancer
; 21(1): 611, 2021 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34034685
8.
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
Liver Int
; 41(12): 2997-3008, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250737
9.
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight.
Int J Mol Sci
; 23(1)2021 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008679
10.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 563, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711003
11.
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO).
Tumori
; 110(3): 203-208, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326240
12.
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
Target Oncol
; 19(3): 359-370, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691295
13.
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value.
Mol Ther Methods Clin Dev
; 29: 473-482, 2023 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37273899
14.
Identification of palliative care needs and prognostic factors of survival in tailoring appropriate interventions in advanced oncological, renal and pulmonary diseases: a prospective observational protocol.
BMJ Open
; 13(5): e065971, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253494
15.
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.
Cancer Chemother Pharmacol
; 92(6): 501-510, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725113
16.
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.
Ther Adv Med Oncol
; 15: 17588359231212184, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38107830
17.
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
Target Oncol
; 18(1): 139-145, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689074
18.
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma.
Sci Rep
; 12(1): 18775, 2022 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335135
19.
Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer.
Biomolecules
; 11(6)2021 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067288
20.
Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer.
Cancers (Basel)
; 13(22)2021 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830826